Focus Area: Quality & Transparency
Bringing data monitoring committee charters into the sunlight
Publication
Published on: May 25, 2023
Published in: National Center for Biotechnology Information, NIH
Description: The authors address the lack of access to the charters of data monitoring committees (DMCs) and call on the NIH to allow their voluntary upload into ClinicalTrials.gov.
DeMets DL, Zarin DA, Rockhold F, Ellenberg SS, Fleming T, Wittes J. Bringing data monitoring committee charters into the sunlight. Clin Trials. 2023 May 25:17407745231169499. doi: 10.1177/17407745231169499. Epub ahead of print. PMID: 37231737.

MRCT Center 2014 Annual Meeting Slides
Bioethics Collaborative Info Sheet 2017
Info Sheet
Published on: November 2017
Developed by: MRCT Center
Impact of Social Media on Clinical Trial Integrity
Meeting Summary
Released on: January 22, 2019
Developed by: MRCT Center Bioethics Collaborative
Data sharing in the context of community-engaged research partnerships
Publication
Published on: May, 2023
Published in: Social Science & Medicine
Description: As data sharing is expanded in the context of greater community engagement in research, we must ask to whom do benefits of data sharing accrue and to whom do benefits not accrue? In an era of growing efforts to engage diverse communities in research, the impact of data sharing for all research participants and the communities that they represent requires the reassessment of the principles of data sharing, incorporating principles of community-engaged research. This article outlines these considerations and proposes new models of benefit sharing.

Enabling Informed Selection of Clinical Trials
Data Safety Monitoring Board Training Videos
Presentation
Presented on: May 19, 2013
Presented at: Workshops at the Society for Clinical Trials Annual Meeting, Boston
Disclosure of Possible Trial Termination to Participants of Interventional Clinical Trials
Publication
Published on: April 4, 2023
Published in: JAMA
Trial termination (the decision to end a trial earlier than planned) has been reported in 17.9% of cardiovascular trials and 16.0% of surgical trials.1,2 Although some trials are terminated for scientific reasons due to safety, efficacy, or futility, many trials are terminated due to inadequate participant enrollment or other nonscientific reasons.


